Table_of_Contents
(Source: JNCI)
Source: JNCI - January 13, 2016 Category: Cancer & Oncology Tags: Cover / Standing Material Source Type: research
Editorial_Board
(Source: JNCI)
Source: JNCI - January 13, 2016 Category: Cancer & Oncology Tags: Cover / Standing Material Source Type: research
Cover
(Source: JNCI)
Source: JNCI - January 13, 2016 Category: Cancer & Oncology Tags: Cover / Standing Material Source Type: research
CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment
Conclusions:
The composite biomarker, CAPG and GIPC1 in primary breast tumors, predicted disease outcomes and benefit from zoledronate and may facilitate patient selection for adjuvant bisphosphonate treatment. (Source: JNCI)
Source: JNCI - January 12, 2016 Category: Cancer & Oncology Authors: Westbrook, J. A., Cairns, D. A., Peng, J., Speirs, V., Hanby, A. M., Holen, I., Wood, S. L., Ottewell, P. D., Marshall, H., Banks, R. E., Selby, P. J., Coleman, R. E., Brown, J. E. Tags: Article Source Type: research
Erratum
(Source: JNCI)
Source: JNCI - January 11, 2016 Category: Cancer & Oncology Tags: Erratum Source Type: research
Response
(Source: JNCI)
Source: JNCI - January 11, 2016 Category: Cancer & Oncology Authors: Sclafani, F., Cunningham, D., Peckitt, C., Watkins, D. Tags: Response Source Type: research
RE: A Randomized Phase II/III Study of Dalotuzumab in Combination With Cetuximab and Irinotecan in Chemorefractory, KRAS Wild-Type, Metastatic Colorectal Cancer
(Source: JNCI)
Source: JNCI - January 11, 2016 Category: Cancer & Oncology Authors: Wen-zhuo, H., Liang-ping, X. Tags: Correspondence Source Type: research
NCI-60 Cell Line Screening: A Radical Departure in its Time
The year 2015 marked the 30th anniversary of National Cancer Institute’s (NCI’s) initial effort to establish a human cell line panel as the basis for discovering new cancer drugs. At its inception, the NCI-60 panel was a controversial departure, born of frustration with previous efforts that employed murine tumors and grounded in the hope that the biology of human tumors was diverse and somehow quite different than the murine leukemia used for the previous 30 years. And while the NCI-60 has not revolutionized cancer drug discovery in terms of the new drugs that resulted, it represents a turning point in the phi...
Source: JNCI - January 11, 2016 Category: Cancer & Oncology Authors: Chabner, B. A. Tags: Commentary Source Type: research
Circulating Metabolites and Survival Among Patients With Pancreatic Cancer
Conclusions:
Prediagnostic circulating levels of TCA cycle intermediates and inherited ACO1 genotypes were associated with survival among patients with pancreatic cancer. (Source: JNCI)
Source: JNCI - January 11, 2016 Category: Cancer & Oncology Authors: Yuan, C., Clish, C. B., Wu, C., Mayers, J. R., Kraft, P., Townsend, M. K., Zhang, M., Tworoger, S. S., Bao, Y., Qian, Z. R., Rubinson, D. A., Ng, K., Giovannucci, E. L., Ogino, S., Stampfer, M. J., Gaziano, J. M., Ma, J., Sesso, H. D., Anderson, G. L., Co Tags: Article Source Type: research
Response
(Source: JNCI)
Source: JNCI - January 7, 2016 Category: Cancer & Oncology Authors: Koshy, M., Malik, R., Mahmood, U., Husain, Z., Weichselbaum, R. R., Sher, D. J. Tags: Response Source Type: research
RE: Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer
(Source: JNCI)
Source: JNCI - January 7, 2016 Category: Cancer & Oncology Authors: Schild, S. E., Ashman, J. B., Keole, S. R., Daniels, T. B., Rule, W. G. Tags: Correspondence Source Type: research
Screening MRI in Women With a Personal History of Breast Cancer
Conclusion:
MRI performance is superior in women with PH compared with women with GFH. Screening MRI warrants consideration as an adjunct to mammography in women with a PH of breast cancer. (Source: JNCI)
Source: JNCI - January 7, 2016 Category: Cancer & Oncology Authors: Lehman, C. D., Lee, J. M., DeMartini, W. B., Hippe, D. S., Rendi, M. H., Kalish, G., Porter, P., Gralow, J., Partridge, S. C. Tags: Article Source Type: research
Erratum
(Source: JNCI)
Source: JNCI - January 4, 2016 Category: Cancer & Oncology Tags: Erratum Source Type: research
Virtual colonoscopy an alternative to fecal occult blood test and colonoscopy for colorectal cancer screening?
(Source: JNCI)
Source: JNCI - December 30, 2015 Category: Cancer & Oncology Tags: Memo to the Media Source Type: research
Colorectal Cancer Screening by Colonoscopy, CT-Colonography, or Fecal Immunochemical Test
(Source: JNCI)
Source: JNCI - December 30, 2015 Category: Cancer & Oncology Authors: Kuipers, E. J., Spaander, M. C. W. Tags: Solicited Editorial Source Type: research
